Metahexamide (INN) is an anti-diabetic drug from the group of sulfonylureas. It is long-acting and belongs to the first-generation cyclohexyl-containing sulfonylureas. It was first described in 1959.[1]
Notes and References
10.1111/j.1749-6632.1959.tb44940.x . Moss JM, Delawter D . Metahexamide in diabetes therapy . Ann NY Acad Sci . 82 . 2. 614–7 . September 1959 . 14424617.
